Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A novel cdk2-selective inhibitor, SU9516, induces apoptosis in colon carcinoma cells.

Lane ME, Yu B, Rice A, Lipson KE, Liang C, Sun L, Tang C, McMahon G, Pestell RG, Wadler S. A novel cdk2-selective inhibitor, SU9516, induces apoptosis in colon carcinoma cells. Cancer Res. 2001 Aug 15; 61(16):6170-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.